Antifungal Drugs: $16.1 Billion Technologies and Global Markets Report 2017-2021 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Antifungal Drugs: Technologies and Global Markets" report to their offering.

The aim of this report is to initially conduct a review of the antifungal drugs currently available, the issues facing the use of antifungal drugs and review some of the latest developments of new and innovative antifungal drugs, their technologies, and their intended clinical applications.

The key objective was also to conduct and provide an analysis of the market value, growth rates, market shares, market development as well as examining the market dynamics and market factors influencing the growth and development of this market. This report also looks at the challenges and potential threats facing the industry, and the factors influencing the market shares of the major market suppliers as well as smaller indigenous manufactures in local markets. The emphasis of this report is to provide the reader with:

A detailed analysis of the revenues and forecasts for the global antifungal drugs market with a further more detailed analysis and forecast of the revenues for the global market sub-divided by major market sub-segments by geographic region and finally by selected country. A detailed analysis of the global market share together with a further more detailed analysis of the market share by geographic regions and finally by selected country.

Report Includes

  • An overview of the global market for antifungal drugs.
  • Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
  • Identification of new antifungal research, development, and drug applications.
  • Heavy focus on therapeutics in early development such as new molecular and biological entities from traditional pharmaceutical sources, naturally derived synthetic chemicals, and biological sources.
  • Information on over the counter (OTC) vs. prescription products.

Profiles of major players in the industry

  • Ferrer Internacional S.A.
  • Enzon Pharmaceuticals Inc.
  • Astellas Pharma Inc.
  • Galderma Pharma SA Galderma SA
  • Gilead Sciences Inc.
  • Glenmark Pharmaceuticals Limited
  • Sigma-Tau Pharma-ceuticals Inc.
  • TEVA Pharmaceuticals Industries Ltd.
  • Valeant Pharmaceuticals International Inc.
  • Dartmouth Pharmaceuticals.

Key Topics Covered:

1: Introduction

2: Executive Summary

3: Introduction To The Global Antifungal Drug Market

4: Common Environmental Fungi

5: Antifungal Agents

6: Summary: Global Market For Antifungal Drugs

7: North American Market For Antifungal Drugs

8: European Market For Antifungal Drugs

9: Asia-Pacific Market For Antifungal Drugs

10: Latin America Market For Antifungal Drugs

11: Middle East/Africa Market For Antifungal Drugs

12: Company Profiles

13: Appendixes

14: Government Regulatory Agencies And Professional Associations

For more information about this report visit http://www.researchandmarkets.com/research/64z8jp/antifungal_drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Over the Counter (OTC) Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Over the Counter (OTC) Drugs